Cellebrite DI (CLBT) Gets a Buy from J.P. Morgan

Tip Ranks
2025.11.13 12:17
portai
I'm PortAI, I can summarize articles.

J.P. Morgan analyst Brian Essex maintained a Buy rating on Cellebrite DI with a $24.00 price target. Essex, a 5-star analyst, has an average return of 11.3% and a 57.14% success rate. Needham's Mike Cikos also issued a Buy rating, while TR reiterated a Hold rating on November 7.

J.P. Morgan analyst Brian Essex maintained a Buy rating on Cellebrite DI today and set a price target of $24.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

According to TipRanks, Essex is a 5-star analyst with an average return of 11.3% and a 57.14% success rate. Essex covers the Technology sector, focusing on stocks such as CrowdStrike Holdings, Fortinet, and JFrog.

In addition to J.P. Morgan, Cellebrite DI also received a Buy from Needham’s Mike Cikos in a report issued today. However, on November 7, TR | OpenAI – 4o reiterated a Hold rating on Cellebrite DI (NASDAQ: CLBT).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.